Results 91 to 100 of about 245,105 (180)

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families

open access: yesOrphanet Journal of Rare Diseases, 2022
Indraneel Banerjee   +7 more
doaj   +1 more source

Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy

open access: yes, 2014
Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line ...
Demirbilek, HÜSEYİN   +6 more
core   +1 more source

Patient-derived induced pluripotent stem cells for precision modelling of monogenic beta cell disorders

open access: yesFrontiers in Endocrinology
Over the past several years, research and technologies involving patient-derived induced pluripotent stem cells (iPSCs) have rapidly advanced, enabling the study of various disease pathologies, including rare pathologies like monogenic disorders of beta ...
Lily Deng, Mansa Krishnamurthy
doaj   +1 more source

A rare case of congenital hyperinsulinism in a child — when morphology determines treatment tactics

open access: yesЛечащий Врач
Background. A clinical case of an encapsulated focal form of congenital hyperinsulinism in a young child is presented. A comprehensive examination was performed, including molecular genetic analysis, radionuclide diagnostics (PET-CT with 18F-DOPA) and ...
L. R. Klimshina   +6 more
doaj   +1 more source

Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation.

open access: yes, 2012
The most common reason for refractory hypoglycemia in newborns is congenital hyperinsulinism. We report a girl with congenital hyperinsulinism due to novel homozygous mutation (c.2041-25 G>A; aberrant splicing mutation) in the ABCC8 gene encoding SUR1 ...
Cetinkaya, Semra   +10 more
core   +1 more source

Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligands S961 and Ins-AC-S2

open access: yesNature Communications
Congenital hyperinsulinism is a rare genetic disease characterized by overproduction of insulin. One class of potential treatments is insulin receptor antagonists like S961 and Ins-AC-S2, which comprise segments for binding each of the two insulin ...
Amber Vogel   +5 more
doaj   +1 more source

[Clinical practice guidelines "Congenital hyperinsulinism"]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Bolmasova AV   +6 more
europepmc   +1 more source

Paroxysmal awakenings and seizures in congenital hyperinsulinism: a late diagnosis

open access: yes, 2016
We describe the case of a 16-month-old girl with congenital hyperinsulinism diagnosed at the age of 11 months, after a history of a single convulsive seizure at 4 months of age, followed by frequent unexplained paroxysmal events related to sleep.
Elena Faleschini   +4 more
core  

Home - About - Disclaimer - Privacy